A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.
Part of paid clinical trials in Peoria, Arizona.
- Sponsor
- Paradigm Biopharmaceuticals Ltd.
- Study ID
- NCT06917404
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Osteoarthritis, Knee
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Pentosan Polysulfate Sodium twice weekly — DRUGSubcutaneous injection, 2 mg/kg twice weekly for 6 weeks
- Placebo — DRUGPlacebo, subcutaneous injection, twice weekly for 6 weeks
Study Details
The purpose of this study is to measure the change in pain and function with subcutaneous injections of pentosan polysulfate sodium (PPS) compared with subcutaneous injections of placebo in participants with knee OA pain. Study details include: * The study duration will be up to 64 weeks. * The treatment duration will be 6 weeks. * The visit frequency will be twice weekly during treatment. * The visit/contact frequency will be every 4-6 weeks during the 52-week Follow-up period. * Approximately 466 participants will be enrolled into this study.
Key Dates
- Start date
- May 29, 2025
- Status verified
- Nov 2025
- Primary completion
- Jul 31, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 466 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: PPSPentosan polysulfate sodium 2mg/kg twice weekly for 6 weeks
- Placebo Comparator: PlaceboPlacebo (Sodium Chloride Injection, 0.9%) twice weekly for 6 weeks
Primary Outcome Measure
Change from baseline at Day 112 in knee pain as assessed by the weekly average of daily pain (ADP) score on the numerical rating scale (NRS) 11-point (0-10) scale. [ Time Frame: Baseline, Daily to Day 112 ]
Central Contacts
- Donna Skerrett+1 (312) 771 9615
Locations (40)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Onyx Clinical Research-Peoria | Peoria | Arizona | 85381 | Shweta Mehta, MD (PRINCIPAL_INVESTIGATOR) |
| Del Sol Research Management, LLC | Tucson | Arizona | 85715 | Vicki Kalen, MD (PRINCIPAL_INVESTIGATOR) |
| Orange County Research Institute | Anaheim | California | 92801 | Steve Sitar, MD (PRINCIPAL_INVESTIGATOR) |
| Core Healthcare Group | Cerritos | California | 90703 | Francisco Badar, MD (PRINCIPAL_INVESTIGATOR) |
| Triwest Research Center | Chula Vista | California | 91910 | Arthur Mabaquiao, MD (PRINCIPAL_INVESTIGATOR) |
| Seaside Medical Group | Oceanside | California | 92058 | Paul Lizotte, MD (PRINCIPAL_INVESTIGATOR) |
| Paragon RX Clinical | Santa Ana | California | 92703 | Kelvin Mai, MD (PRINCIPAL_INVESTIGATOR) |
| Encompass Clinical Research | Spring Valley | California | 91978 | Hanid Audish, MD (PRINCIPAL_INVESTIGATOR) |
| Focus Clinical Research | West Hills | California | 91307 | Hessam Aazami, MD (PRINCIPAL_INVESTIGATOR) |
| Clinical Research of West Florida - Clearwater | Clearwater | Florida | 33765 | Robert Levin, MD (PRINCIPAL_INVESTIGATOR) |
| GNP Research | Cooper City | Florida | 33024 | Mark Jaffe, MD (PRINCIPAL_INVESTIGATOR) |
| Arrow Clinical Trials | Daytona Beach | Florida | 32117 | David Billmeier, MD (PRINCIPAL_INVESTIGATOR) |
| AGA Clinical Trials | Hialeah | Florida | 33012 | Dario Altamirano, MD (PRINCIPAL_INVESTIGATOR) |
| Evolution Clinical Trials | Miami | Florida | 33122 | Gilberto Perez, MD (PRINCIPAL_INVESTIGATOR) |
| Well Pharma Medical Research | Miami | Florida | 33173 | Eddie Armas, MD (PRINCIPAL_INVESTIGATOR) |
| K2 Medical Research | Orlando | Florida | 32806 | Beatriz Colon, MD (PRINCIPAL_INVESTIGATOR) |
| Progressive Medical Research | Port Orange | Florida | 32127 | Richard Mohammed, MD (PRINCIPAL_INVESTIGATOR) |
| Phoenix Clinical Research | Tamarac | Florida | 33321 | Richard Berkowitz, MD (PRINCIPAL_INVESTIGATOR) |
| Conquest Research | Winter Park | Florida | 32789 | Anand Patel, MD (PRINCIPAL_INVESTIGATOR) |
| Chicago Clinical Research, Inc | Chicago | Illinois | 60607 | Dennis Levinson, MD (PRINCIPAL_INVESTIGATOR) |
| Northwestern University | Chicago | Illinois | 60611 | Thomas Schnitzer, MD (PRINCIPAL_INVESTIGATOR) |
| Sinai Hospital of Baltimore | Baltimore | Maryland | 21215 | James Nace, MD (PRINCIPAL_INVESTIGATOR) |
| Profound Research | Farmington Hills | Michigan | 48334 | Barry Feldman, MD (PRINCIPAL_INVESTIGATOR) |
| Insight Research Institute | Flint | Michigan | 48507 | Vincent Rampersaud, MD (PRINCIPAL_INVESTIGATOR) |
| Rochester Medical Group | Rochester Hills | Michigan | 48307 | Michael Margolis, MD (PRINCIPAL_INVESTIGATOR) |
| Onyx Clinical Research - Rochester Hills | Troy | Michigan | 48085 | Ramkrishna Surendran, MD (PRINCIPAL_INVESTIGATOR) |
| Physician Research Collaboration | Lincoln | Nebraska | 68516 | Melvin Churchill, MD (PRINCIPAL_INVESTIGATOR) |
| Alpine Healthcare Family Practice | Las Vegas | Nevada | 89109 | Robert Kaplan, MD (PRINCIPAL_INVESTIGATOR) |
| Drug Trials America | Hartsdale | New York | 10530 | Michael Gerdis, MD (PRINCIPAL_INVESTIGATOR) |
| Groth Pain & Spine - Long Island, NY | Mineola | New York | 11501 | Mariyam Wasay, MD (PRINCIPAL_INVESTIGATOR) |
| IMA Clinical Research Manhattan | New York | New York | 10036 | James Greenwald, MD (PRINCIPAL_INVESTIGATOR) |
| Groth Pain and Spine Management | Smithtown | New York | 11787 | Christopher Amen, MD (PRINCIPAL_INVESTIGATOR) |
| FutureSearch Trials of Neurology | Austin | Texas | 78731 | Gregory Tempest, MD (PRINCIPAL_INVESTIGATOR) |
| FutureSearch Trials of Dallas | Dallas | Texas | 75251 | Michael Downing, MD (PRINCIPAL_INVESTIGATOR) |
| Clinical Trial Network | Houston | Texas | 77074 | Alan Reichman, MD (PRINCIPAL_INVESTIGATOR) |
| DM Clinical Research | Houston | Texas | 77065 | Tiffany Huynh, MD (PRINCIPAL_INVESTIGATOR) |
| Vilo Research Group | Houston | Texas | 77017 | Luis Zepeda, MD (PRINCIPAL_INVESTIGATOR) |
| Epic Clinical Research | Lewisville | Texas | 75057 | Manjoo Sharma, MD (PRINCIPAL_INVESTIGATOR) |
| Quality Research Inc. | San Antonio | Texas | 78209 | Robert Morin, MD (PRINCIPAL_INVESTIGATOR) |
| Rio Clinical Trials | Ogden | Utah | 84404 | Stephen Bruce, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Peoria, AZ
Related Studies
- Physica System Total Knee Replacement Registry StudyRecruiting · Limacorporate S.p.a · Rancho Mirage, California
- Surgical Joint Registry MBJRFEnrolling By Invitation · Memorial Bone and Joint Research Foundation · Houston, Texas
- Navio Robotic Versus Conventional Total Knee ArthroplastyRecruiting · Columbia University · New York, New York
- A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee OsteoarthritisPHASE2/PHASE3 · Recruiting · Nature Cell Co. Ltd. · El Cajon, California